Significantly, the lowest blood degree of IgG following a dose increased by 23.8 % in those patients on the higher dose of SCIg, compared to 8.6 % in those on the lower dosage of SCIg. ‘These data claim that the higher dosage of Hizentra provides better protection from disease and its consequences in patients with major immunodeficiencies,’ said Dr. John Hagan, Associate Professor of Medication in the Divisions of Allergic Illnesses and Primary Immunodeficiencies of the Mayo Clinic in Rochester, MN and lead writer of the study.This is the first study showing that in individuals who are getting treated for hip impingement with arthroscopy, not only do we bring back their mechanical measurements, but in so doing, we’ve improved their functional flexibility over the joint, stated Bryan T. Kelly, M.D., co-director of the guts for Hip Preservation and Pain at Hospital for Particular Surgery in New York. This study received the 2011 Excellence in Study Award from the American Orthopaedic Culture for Sports Medicine. In recent years, a hip condition referred to as femoro-acetabular impingement or hip impingement is becoming widely recognized among the most common factors behind early osteoarthritis in the hip.